55513-843 : Aimovig 140 mg/ml Subcutaneous Injection, Solution


NDC55513-843
Labeler: Amgen Inc
Product Type: Human Prescription Drug
Drug Name:  Aimovig
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761077
Rev. Date: 


NDC Package Codes:

  • 55513-843-01: 1 SYRINGE IN 1 CARTON (55513‑843‑01) > 1 ML IN 1 SYRINGE

Active Ingredients:

  • Erenumab-aooe

Dosage Strength:

  • 140 mg/mL

Related Products:

Based on records with the same trade name.
  • 55513-840 Aimovig 70 mg/ml Subcutaneous Injection by Amgen Inc
  • 55513-841 Aimovig 70 mg/ml Subcutaneous Injection by Amgen Inc
  • 55513-842 Aimovig 140 mg/ml Subcutaneous Injection, Solution by Amgen Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 55513-843 QR Code

< Prev: 55513-842Next: 55513-880 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 10 May 2019.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA